Transaction in Own Shares

Summary by AI BETAClose X

Ryanair Holdings plc announced that between December 15 and December 19, 2025, it repurchased 4,700 ordinary shares at an average price of €29.49 and 307,276 ordinary shares underlying American Depositary Shares for cancellation, with the latter averaging between US $35.49 and US $36.16. These purchases are part of the company's ongoing share buy-back program initiated on May 20, 2025, with weekly updates on these transactions to be provided.

Disclaimer*

Ryanair Holdings PLC
22 December 2025
 

Ryanair Holdings plc

Transactions in own shares

Ryanair Holdings plc (the "Company") announces that in the period 15 December 2025 to 19 December 2025 it purchased for cancellation in aggregate 4,700 ordinary shares of nominal value €0.006 each in the capital of the Company ("Ordinary Shares") and in aggregate 307,276 Ordinary Shares underlying the American Depositary Shares, as further detailed below.

Date

Number of Ordinary Shares

Volume weighted average price paid

Number of Ordinary Shares underlying American Depositary Shares

Volume weighted average price paid

15 December 2025

900

€29.827

64,292

US $35.6861

16 December 2025

412

€29.470

64,322

US $35.4977

17 December 2025

1,700

€29.497

64,216

US $35.6373

18 December 2025

900

€29.460

64,238

US $35.8220

19 December 2025

788

€29.606

50,208

US $36.1617

 

These share purchases form part of the Company's existing share buy-back programme, details of which were announced on 20 May 2025 (the "Programme").  Purchases made under the share buyback programme will be announced on a weekly basis.

 

All shares purchased by the Company will be cancelled. This announcement is being made in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended. 

Issuer name:


Ryanair Holdings plc


LEI


635400BR2ROC1FVEBQ56

ISIN:


IE00BYTBXV33

 

Enquiries:

Contact:

Jamie Donovan

Ryanair Holdings Plc

Tel: + 353 1 945 1212

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings